Sector: Health Care.Industry: Pharmaceuticals
Palisade Bio Inc is a late-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-14
REV
Q1 2021Est.ActualSurprise
EPS-0.790
REV0

Related Companies

TickerCompanyChg %Mkt Cap
PALIPalisade Bio-1.47%

Palisade Bio Frequently Asked Questions

Q

How do I buy Palisade Bio (PALI) stock?

A

You can purchase shares of Palisade Bio (NASDAQ: PALI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Palisade Bio's (PALI) competitors?

Q

What is the target price for Palisade Bio (PALI) stock?

A

There is no analysis for Palisade Bio

Q

Current Stock Price for Palisade Bio (PALI)?

A

The stock price for Palisade Bio (NASDAQ: PALI) is $4.09 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Palisade Bio (PALI) pay a dividend?

A

There are no upcoming dividends for Palisade Bio.

Q

When is Palisade Bio (NASDAQ:PALI) reporting earnings?

A
Palisade Bio’s Q2 earnings are confirmed for after-market on August 14, 2021.
Q

Is Palisade Bio (PALI) going to split?

A

There is no upcoming split for Palisade Bio.

Q

What sector and industry does Palisade Bio (PALI) operate in?

A

Palisade Bio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.